Patient Characteristics
| Gleason score | Previous therapy | ||||||||||
| Patient no. | Age (y) | Weight (kg) | 7 | >7 | PSA (ng/mL) | AT | CT | EBRT | RALP | LND | IT |
| 1 | 65 | 78 | 9 | 93 | 1 | 1 | |||||
| 2 | 55 | 89 | 8 | 18 | 1 | 1 | 1 | ||||
| 3 | 74 | 90 | 7 | 43 | 1 | 1 | 1 | ||||
| 4 | 68 | 79 | 10 | 8 | 1 | 1 | |||||
| 5 | 66 | 83 | 8 | 54 | 1 | 1 | 1 | ||||
| 6 | 60 | 85 | 9 | 137 | 1 | 1 | 1 | ||||
| 7 | 54 | 98 | 7 | 2 | 1 | 1 | |||||
| 8 | 72 | 84 | 7 | 54 | 1 | 1 | |||||
| 9 | 54 | 85 | 9 | 2 | 1 | ||||||
| 10 | 54 | 108 | 9 | 226 | 1 | 1 | 1 | ||||
| 11 | 71 | 81 | 8 | 39 | 1 | 1 | |||||
| 12 | 70 | 101 | 8 | 49 | 1 | ||||||
PSA = prostate-specific antigen level at time of PET/CT; AT = antihormone therapy; CT = chemotherapy; EBRT = external-beam radiotherapy; RALP = robot-assisted laparoscopic prostatectomy; LND = lymph node dissection; IT = immunotherapy.